Jornadas Mediteraneas

Global Stem Cells Group Research Director Martiza Novas Recognized for Her Work in Regenerative Medicine

MIAMI, Dec. 22, 2017—Maritza Novas Research Director, Global Stem Cells Group, earned recognition for her work and achievements in regenerative medicine at the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity, Dec. 2, 2017, in Mexico City.

Novas has been in the forefront of medical and anti-aging medicine since 2001. The recognition, signed and presented to her by Congress President Rector Doctor Arturo Conde at the event, honored her for 10 years of dedicated service educating others on clinical applications of stem cells.

A pioneer in the use of stem cells for therapeutic procedures, pain management, and treatment of chronic degenerative conditions, Novas has trained more than 2,000 physicians worldwide on procedures and protocols for harvesting and isolating adipose-derived stem cells for autologous re-implantation, and with problem-solving methods to improve patient outcomes.

Novas specializes in stem cell procedures for anti-aging applications, tissue regeneration, functional medicine, age management, bio-identical hormone therapy, and weight control. Novas has been a certified ISSCA specialist for more than four years.

As a member of Stem Cell Training, Inc.’s research and development team, Novas has assisted in the development of new proprietary adipose and bone marrow protocols currently being used in the company’s comprehensive stem cell training courses.

Novas earned a medical degree at the University of Havana, Cuba in 1993. Novas, Director of Research and Development for Global Stem Cells Group, has been in the forefront of medical and anti-aging medicine since 2001.

She has been a member of the American Academy of Anti-Aging Medicine since 2004 and draws upon 10 years of combined experience with therapeutic procedures, hormonal replacement and nutritional therapies, liposculpture, and fat transfers. Novas is currently completing a master’s degree in Molecular Biology at Lehigh University.

For more information, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global Stem Cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

 

Maritza Novas recognized

StemData relaunch

Global Stem Cells Group has announced the relaunch of its StemData cloud-based electronic medical record system specifically designed for regenerative medicine practitioners.

MIAMI, Nov. 29, 2017—Global Stem Cells Group, a world leader in stem cell and regenerative medicine, has announced the relaunch of its StemData software, the first cloud-based electronic medical record system specifically designed for regenerative medicine practitioners.

The StemData system, initially launched in September 2016, is a customized software program for physicians who operate a regenerative medicine practice. The StemData software empowers physicians to follow patients throughout their treatment schedules. The StemData program comes programmed with the latest point-of-care regenerative medicine protocols and follow-up procedures to make it easy for stem cell patients to schedule appointments by phone, and for practitioners to document patient progress and gather important data to establish the safety and efficacy of stem cell treatments in the physician’s office environment.

The StemData system app is marketed exclusively through Global Stem Cells Group and will be provided free of charge to affiliate physicians in the Stem Cell Center network.

StemData’s cloud-based, server-less solution is accessible via web, iPad, iPhone, Google Glass and Apple Watch. Global Stem Cells Group has utilized the development of the latest electronic medical record (EMR) systems to bring intelligent EMR technology to regenerative medicine specialists.

The StemData app helps regenerative medicine practitioners increase efficiencies in their medical practices while improving both treatment and business outcomes. The app will intuitively adapt to each individual practitioner’s unique practice preferences.

To learn more about GSCG’s StemData solution, visit http://www.stemdata.org, email info@stemcellsgroup.com, or call +1305 560 5337.

About Global Stem Cells Group:

stemdata relaunch


Global Stem Cells Group
(GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global Stem Cell Group’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.

stemdata relaunch

ISSCA Buenos Aires

The International Association for Stem Cell Application moved to a new office at Piedra 383 at Ciudad Autonoma of Buenos Aires, Argentina. The move accommodates ISSCA’s increasing specialty and patient volume, as well as its expanding regenerative medicine certification training programs.

MIAMI, Nov. 29, 2017—The International Association for Stem Cell Application (ISSCA) has announced the move of its Puerto Madero office in Buenos Aires to a new location just a few blocks away to Piedra 363. The new location will house an ISSCA regional office and treatment center.

ISSCA Buenos Aires

The move to the larger office reflects ISSCA’s need to accommodate rapidly expanding patient volume and specialty offerings at its Buenos Aires center. The larger clinical and office space will allow ISSCA to continue providing superior services to patients traveling from the U.S, and worldwide for regenerative medicine treatments. The new location includes a dedicated conference room to host ongoing regenerative medicine training programs and more than three new procedure rooms.

ISSCA celebrated the new location’s grand opening Nov. 26-27, 2017, and host ISSCA regenerative medicine certification training courses for physicians.

To learn more about the ISSCA’s Buenos Aires center and training courses, visit the ISSCA website, email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Buenos Aires

Magellan Autologous

                                                                            Magellan Autologous Platelet Separator

Global Stem Cells Group and its subsidiary Adimarket named representatives for Magellan Autologous Platelet Separator in Latin America and Middle East.

 MIAMI, Nov. 29, 2017— Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, and its subsidiary Adimarket have been named to represent the Magellan Autologous Platelet Separator in Latin America and Middle East.

Developed by Arteriorcyte Medical Systems, a leading medical device company headquartered in Hopkinton, Mass., the Magellan Autologous Platelet Separator is a high-tech, automated dual spin processing system designed for use in clinical laboratories or intraoperatively at the point-of-care for safe and rapid preparation of high-quality, platelet-rich plasma (PRP) as well as platelet poor plasma (PPP).

Global Stem Cells Group CEO Benito Novas says the Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.

“We share Arteriocyte’s commitment to research and development of blood component technology to advance treatments that benefit patients in the field of regenerative medicine,” Novas says. “The Magellan system furthers GSCG’s drive to invest in platelet separation technologies that focus on the development of new surgical applications for PRP and elevates these technologies to the next level.”

The fully-automated Magellan system is specifically designed to fractionate blood at bedside without a need for manual manipulation. At the end of its cycle, the Magellan PRP is delivered into a collection syringe, ready for immediate application.

As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations. The system can be programmed to deliver a volume of 3 – 10 mL from each processing cycle, allowing practitioners to customize the concentration per mL within the PRP.  The Magellan system is approved for three processing cycles per disposable separation chamber, allowing for a maximum of 30 mL of product.

For more information, visit the Adimarket regenerative medicine online store website, email info@stemcellsgroup.com, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.

Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.

About Arteriorcyte Medical Systems:
Magellan Autologous Platelet Separator
Arteriocyte Medical Systems, Inc. is a leading medical device company committed to developing and marketing novel medical products to help patients heal faster. Established in 2007 by Arteriocyte, Inc. and DW Healthcare Partners, Arteriocyte Medical Systems is devoted to providing innovative solutions to patients and medical professionals to address serious unmet medical needs particularly in cardiac, orthopedic and vascular surgeries.

###

Magellan Autologous platelet separator

ISSCA Miami

ISSCA will conduct the first regenerative medicine certification training course for the upcoming year in Miami Feb. 2-3, 2018. The two-day course focuses on pain management and aesthetic regenerative medicine protocols.

MIAMI, Nov. 20, 2017—The International Society for Stem Cell Application (ISSCA) announced plans to hold its first regenerative medicine certification training course of the upcoming year Feb. 2 – 3, 2018 in Miami.

The two-day, hands-on training course focuses on pain management and aesthetic regenerative medicine protocols. Practitioners learn skills that can be used to treat patients in their practices, and for career advancement. The course provides participating physicians with training in stem cell applications to benefit patients undergoing aesthetic procedures or being treated for specific medical condtions.

Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.

The ISSCA pain management and aesthetic regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow.

Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.

To learn more about the training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 

Cidranes ISSCA

 

Ernesto Miguel Delgado Cidranes, M.D., Ph.D., appointed regional director of ISSCA chapter in Europe.

MIAMI, Nov. 22, 2017—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Ernesto Miguel Delgado Cidranes, M.D., Ph.D., Regional Director of the ISSCA chapter in Europe.

Cidranes is an anesthesiologist and resuscitation and intensive care specialist in, Madrid, Spain. He is a renowned expert in pain management and promotes an integrative and interdisciplinary approach to the treatment of pain. Cidranes’s areas of expertise include interventional pain management, pain treatment, stem cell therapies, and regenerative medicine.

As the European regional director, Cidranes will promote ISSCA activities in EU, and collaborate with the organization to establish new standards for regenerative medicine protocols worldwide. Cidranes will conduct a specialized training workshop in pain management and cosmetic gynecology Feb. 25-26, 2018 in Madrid, Spain, and plans to promote the workshop throughout Europe.

He is director, CEO, and founder at Advanced Pain and Aesthetic Management Center in Madrid, and serves on the advisory board for ISSCA affiliate Global Stem Cells Group. Cidranes is also head of service at the La Milagrosa Hospital Pain Unit and the Pain Unit Los Madronas Hospital, both in Madrid.

He serves as a medical specialist in anesthesiology-reanimation and pain therapy at the Hospital Ramon y Cajal in Madrid, and an editorial board member of the Journal Pain Management and Therapy. Cidranes is also a popular international speaker on pain management, stem cell therapies, regenerative medicine, and ultrasound techniques.

“It is a pleasure to have Dr. Cidranes representing ISSCA in Europe, and as a collaborator in our efforts to establish new regenerative medicine standards worldwide,” He brings a wealth of experience and expertise to the ISSCA organization.”

To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 

ISSCA Hoyos

 

ISSCA Hoyos

 

Alfredo Hoyos, M.D., appointed regional director of ISSCA chapter in Venezuela, Colombia, Ecuador, and Peru.

MIAMI, Nov. 22, 2017—The International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., announced the appointment of Alfredo Hoyos, M.D., Regional Director of the ISSCA chapter in Venezuela, Colombia, Ecuador, and Peru.

As regional director, Hoyos will promote ISSCA activities in those countries and collaborate with the organization to establish new standards for regenerative medicine protocols. Hoyos will be in charge of organizing two hands-on stem cell training courses to be held in Bogota March 2-3 and July 6-7, 2018. Hoyos will also be in charge of the International Regenerative Medicine Symposium to be held in Bogota in July, 2018.

Hoyos is a world-renowned board-certified plastic surgeon from Bogota, Colombia, specializing in aesthetic plastic surgery, maxillofacial surgery, and hand surgery. He earned his medical degree from El Rosario University, Colombia, and completed visiting fellowships in aesthetic surgery at New York University, in maxillofacial surgery at Mount Sinai Hospital in New York, and in facial aesthetic surgery at Manhattan Eye, Ear and Throat Hospital in New York. He serves as chief scientific officer for ISSCA affiliate Global Stem Cells Group in Miami.

Hoyos invented high definition liposculpture (HDL) and dynamic definition in lipoplasty (4D) techniques, as well as other advanced techniques focused on body contouring. He has also refined techniques in fat transfer (buttock and pectoral lipograft) and breast augmentation.

“We are proud to have Dr. Hoyos representing ISSCA in South America, and look forward to working with him to promote ISSCA pursuits,” says Kim. “His expertise will significantly enhance our collaborative efforts to establish new standards for regenerative medicine protocols worldwide.”

To learn more about the ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 

 

Aesthetic Polyclinic Abu Dhabi

 

 

 

 

 

Aesthetic Polyclinic Abu Dhabi

Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.

MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, has added Aesthetic Polyclinic to its worldwide regenerative medicine network, naming it the exclusive representative for GSCG in Abu Dhabi.

This new alliance is part of Global Stem Cells Group’s worldwide expansion of its clinical presence, partnering with qualified physicians experienced in stem cell therapies to open new clinics and utilize GSCG stem cell products and protocols in patient treatments. To date, GSCG has established similar alliances in 32 cities worldwide.

Aesthetic Polyclinic will provide advanced stem cell protocols and state-of-the-art techniques in stem cell therapies to patients from around the world. Aesthetic Polyclinic is GSCG’ fourth clinical presence in the Middle East, including Morocco, Iraq, and Pakistan.

Aesthetic Polyclinic specializes in plastic surgery, aesthetic medicine, dermatology, and general and cosmetic dentistry. The alliance with GSCG will add the benefits of stem cell applications for aesthetic and anti-aging treatments to the organization’s catalog of patient services. According to Sela Al Asadi, Managing Director for Aesthetic Polyclinic, the alliance is ideally suited to both organizations’ mission.

“Like Global Stem Cells Group, we are committed to meeting the growing needs of our clients and patients, and we continuously search for and adopt the latest medical technology and services,” Al Asadi says. “Our staff of committed, efficient, and customer-centric professionals is excited to represent Global Stem Cells Group and offer the benefits of their regenerative medicine products and protocols to our patients.”

Global Stem Cells Group provides stem cell treatments for a variety of conditions, diseases, and aesthetic treatments at facilities worldwide. The new facility will have an international staff that is experienced in administering the leading cellular therapies available.

Global Stem Cells Group’s Abu Dhabi clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

Global Stem Cells Group is committed to providing the highest standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

To learn more about Global Stem Cells Group, visit the GSCG website,  email info@stemcellsgroup.com, or call +1305 560 533

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global Stem Cell Group’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.

About Aesthetic Polyclinic

Aesthetic Polyclinic has been serving the residents of Abu Dhabi and Al Ain since 2000, providing world-class aesthetic services including plastic surgery dermatology, IPL hair removal, cosmetic and general dentistry, weight loss and body treatments, and specialized skin care.

One of Abu Dhabi’s top healthcare clinics, Aesthetic Polyclinic values the distinctly individual nature of all its clients and patients and prides itself in delivering quality customer service through customer focus, innovation, cutting-edge technology, and a commitment to excellence.

Formerly Aesthetic Skincare, it became Aesthetic Polyclinic in 2009 upon introducing dermatology and plastic surgery services. In 2013, the organization expanded its medical services with a brand new, state-of-the-art dedicated medical building and introducing dental and orthodontic services.

###

Aesthetic Polyclinic

 

XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery

 

 

 

 

 

 

 

The International Society for Stem Cell Application (ISSCA), and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity. ISSCA and GSCG will launch their new online regenerative medicine training course, and will also launch a new adipose stem cell isolation kit, STEMPIA, at the event.

XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery .                   XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery


MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in promoting education and setting standards in regenerative medicine, in collaboration with and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity Nov. 30 – Dec. 3, 2017, in Mexico City.

Hosted by the Institute of Higher Studies in Medicine (IESM), the annual International Congress is among the largest and most well-attended aesthetic medicine events in Ibero-America. More than 1,000 physicians from around the world are expected to attend. This year’s speaker lineup includes a renowned group of professionals in the field of regenerative medicine.

ISSCA and GSCG plan to leverage the large gathering of regenerative medicine and healthcare professionals at the International Congress to launch the newest cutting-edge online regenerative medicine training course in collaboration with Stem Cell Training, Inc.

The new virtual regenerative medicine training course is designed to instruct qualified physicians in the theoretical and practical protocols necessary to effectively and expertly administer regenerative medicine procedures to their patients. Training includes instructions for harvesting and isolating stem cells. The online training program positions physicians to provide stem cell procedures in their existing practice or open a stem cell center practice and join ISSCA’s international network of stem cell specialists.

In addition, the organizations will launch STEMPIA, a new adipose-derived stem call kit. The kit provides two specially designed tubes to isolate and concentrate adipose tissue-derived stromal vascular fraction (SVF). STEMPIA offers an easier, more effective, and shorter process for SVF isolation while maintaining high viability rates. STEMPIA uses less consumables and tools compared to manual SVF isolation processes, saving both costs and time in the SVF isolation process.

ISSCA, and GSCG will also be conducting a two-day, intensive regenerative medicine certification course for qualified physicians in Mexico City following the congress. Attendees will gain hand-on training and learn how to harvest and isolate stem cells, and expertly administer stem cell treatments to patients.. Upon completing the course, participants will receive certification and will be able to use their skills to treat patients in their practice, and for career advancement.

Fiesta Americana Reforma is the conference venue and headquarters. Visit the hotel data website page for location and additional information.

To learn more about the International Conference, visit the conference website email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.

###

XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity

regenerative-medicine-certification-training

 

 

 

 

 

 

 

The International Association for Stem Cell Application (ISSCA) will be conducting a regenerative medicine certification course for physicians in Buenos Aires Nov. 26-27, 2017. The two-day intensive training course teaches trainees extraction, isolation, and application of PRP, adipose, and bone marrow stem cells.

 

regenerative medicine certification training

MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine training, has announced plans to conduct regenerative medicine certification training for physicians in Buenos Aires, Argentina November 26 – 27, 2017.

The ISSCA training course, available to qualified physicians interested in adding regenerative medicine to their practice procedures, provides hands-on, practical instruction under the guidance of trained medical experts in a highly visual, interactive, and clinical learning environment.

.ISSCA’s medical professionals teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells. Trainees will participate in different medical cases under the supervision of trained specialists.

This hands-on stem cell training course provides each participant with a live demonstration of the extraction, isolation, and application of PRP, adipose, and bone marrow stem cells. Techniques and materials used in the course, along with high-resolution, step-by-step procedure videos are provided for the participating physician’s future use and reference.

Led by ISSCA’s established team of skilled practitioners, this course is designed specifically to provide personalized instruction. Seats for each course are limited to 8-10 trainees, not only to suit each participant’s individual training needs but also to allow for professional networking.

Participants who complete the training will receive certification that documents their participation in and completion of the training, their and their knowledge and skills in the field of regenerative medicine. Certification candidates are required to provide proof of prior medical training and experience, and successfully complete a written as well as an oral/practical exam. Certification confirms a physician’s expertise in regenerative medicine.

​Certification procedures and requirements are key to the integrity of regenerative medicine. They furnish a reputable credential that is essential not only for patients to see, but also to a physician’s practice.

The Buenos Aires certification training course will mark the 11th event ISSCA has sponsored and hosted thus far in 2017. The organization is working to position itself as a reference point for regenerative medical practitioners worldwide. With a presence in more than 25 countries, physicians interested in certification can check for an ISSCA training course near them by visiting the https://www.stemcelltraining.net/ website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

.                                                                                                               ###
Regenerative medicine certification training